1 Report Business Overview 1.1 Study Scope 1.2 Market Analysis by Type 1.2.1 Global Hepatitis Therapeutics Market Size Growth Rate by Type, 2017 VS 2021 VS 2028 1.2.2 Hepatitis Vaccine 1.2.3 Anti-Viral Drugs 1.3 Market by Application 1.3.1 Global Hepatitis Therapeutics Market Size Growth Rate by Application, 2017 VS 2021 VS 2028 1.3.2 Hepatitis A 1.3.3 Hepatitis B 1.3.4 Hepatitis C 1.3.5 Alcoholic Hepatitis 1.3.6 Others 1.4 Study Objectives 1.5 Years Considered 2 Global Growth Trends 2.1 Global Hepatitis Therapeutics Market Perspective (2017-2028) 2.2 Hepatitis Therapeutics Growth Trends by Region 2.2.1 Hepatitis Therapeutics Market Size by Region: 2017 VS 2021 VS 2028 2.2.2 Hepatitis Therapeutics Historic Market Size by Region (2017-2022) 2.2.3 Hepatitis Therapeutics Forecasted Market Size by Region (2023-2028) 2.3 Hepatitis Therapeutics Market Dynamics 2.3.1 Hepatitis Therapeutics Industry Trends 2.3.2 Hepatitis Therapeutics Market Drivers 2.3.3 Hepatitis Therapeutics Market Challenges 2.3.4 Hepatitis Therapeutics Market Restraints 3 Competition Landscape by Key Players 3.1 Global Top Hepatitis Therapeutics Players by Revenue 3.1.1 Global Top Hepatitis Therapeutics Players by Revenue (2017-2022) 3.1.2 Global Hepatitis Therapeutics Revenue Market Share by Players (2017-2022) 3.2 Global Hepatitis Therapeutics Market Share by Company Type (Tier 1, Tier 2, and Tier 3) 3.3 Players Covered: Ranking by Hepatitis Therapeutics Revenue 3.4 Global Hepatitis Therapeutics Market Concentration Ratio 3.4.1 Global Hepatitis Therapeutics Market Concentration Ratio (CR5 and HHI) 3.4.2 Global Top 10 and Top 5 Companies by Hepatitis Therapeutics Revenue in 2021 3.5 Hepatitis Therapeutics Key Players Head office and Area Served 3.6 Key Players Hepatitis Therapeutics Product Solution and Service 3.7 Date of Enter into Hepatitis Therapeutics Market 3.8 Mergers & Acquisitions, Expansion Plans 4 Hepatitis Therapeutics Breakdown Data by Type 4.1 Global Hepatitis Therapeutics Historic Market Size by Type (2017-2022) 4.2 Global Hepatitis Therapeutics Forecasted Market Size by Type (2023-2028) 5 Hepatitis Therapeutics Breakdown Data by Application 5.1 Global Hepatitis Therapeutics Historic Market Size by Application (2017-2022) 5.2 Global Hepatitis Therapeutics Forecasted Market Size by Application (2023-2028) 6 North America 6.1 North America Hepatitis Therapeutics Market Size (2017-2028) 6.2 North America Hepatitis Therapeutics Market Size by Type 6.2.1 North America Hepatitis Therapeutics Market Size by Type (2017-2022) 6.2.2 North America Hepatitis Therapeutics Market Size by Type (2023-2028) 6.2.3 North America Hepatitis Therapeutics Market Share by Type (2017-2028) 6.3 North America Hepatitis Therapeutics Market Size by Application 6.3.1 North America Hepatitis Therapeutics Market Size by Application (2017-2022) 6.3.2 North America Hepatitis Therapeutics Market Size by Application (2023-2028) 6.3.3 North America Hepatitis Therapeutics Market Share by Application (2017-2028) 6.4 North America Hepatitis Therapeutics Market Size by Country 6.4.1 North America Hepatitis Therapeutics Market Size by Country (2017-2022) 6.4.2 North America Hepatitis Therapeutics Market Size by Country (2023-2028) 6.4.3 U.S. 6.4.4 Canada 7 Europe 7.1 Europe Hepatitis Therapeutics Market Size (2017-2028) 7.2 Europe Hepatitis Therapeutics Market Size by Type 7.2.1 Europe Hepatitis Therapeutics Market Size by Type (2017-2022) 7.2.2 Europe Hepatitis Therapeutics Market Size by Type (2023-2028) 7.2.3 Europe Hepatitis Therapeutics Market Share by Type (2017-2028) 7.3 Europe Hepatitis Therapeutics Market Size by Application 7.3.1 Europe Hepatitis Therapeutics Market Size by Application (2017-2022) 7.3.2 Europe Hepatitis Therapeutics Market Size by Application (2023-2028) 7.3.3 Europe Hepatitis Therapeutics Market Share by Application (2017-2028) 7.4 Europe Hepatitis Therapeutics Market Size by Country 7.4.1 Europe Hepatitis Therapeutics Market Size by Country (2017-2022) 7.4.2 Europe Hepatitis Therapeutics Market Size by Country (2023-2028) 7.4.3 Germany 7.4.4 France 7.4.5 U.K. 7.4.6 Italy 7.4.7 Russia 7.4.8 Nordic Countries 8 Asia-Pacific 8.1 Asia-Pacific Hepatitis Therapeutics Market Size (2017-2028) 8.2 Asia-Pacific Hepatitis Therapeutics Market Size by Type 8.2.1 Asia-Pacific Hepatitis Therapeutics Market Size by Type (2017-2022) 8.2.2 Asia-Pacific Hepatitis Therapeutics Market Size by Type (2023-2028) 8.2.3 Asia-Pacific Hepatitis Therapeutics Market Share by Type (2017-2028) 8.3 Asia-Pacific Hepatitis Therapeutics Market Size by Application 8.3.1 Asia-Pacific Hepatitis Therapeutics Market Size by Application (2017-2022) 8.3.2 Asia-Pacific Hepatitis Therapeutics Market Size by Application (2023-2028) 8.3.3 Asia-Pacific Hepatitis Therapeutics Market Share by Application (2017-2028) 8.4 Asia-Pacific Hepatitis Therapeutics Market Size by Region 8.4.1 Asia-Pacific Hepatitis Therapeutics Market Size by Region (2017-2022) 8.4.2 Asia-Pacific Hepatitis Therapeutics Market Size by Region (2023-2028) 8.4.3 China 8.4.4 Japan 8.4.5 South Korea 8.4.6 Southeast Asia 8.4.7 India 8.4.8 Australia 9 Latin America 9.1 Latin America Hepatitis Therapeutics Market Size (2017-2028) 9.2 Latin America Hepatitis Therapeutics Market Size by Type 9.2.1 Latin America Hepatitis Therapeutics Market Size by Type (2017-2022) 9.2.2 Latin America Hepatitis Therapeutics Market Size by Type (2023-2028) 9.2.3 Latin America Hepatitis Therapeutics Market Share by Type (2017-2028) 9.3 Latin America Hepatitis Therapeutics Market Size by Application 9.3.1 Latin America Hepatitis Therapeutics Market Size by Application (2017-2022) 9.3.2 Latin America Hepatitis Therapeutics Market Size by Application (2023-2028) 9.3.3 Latin America Hepatitis Therapeutics Market Share by Application (2017-2028) 9.4 Latin America Hepatitis Therapeutics Market Size by Country 9.4.1 Latin America Hepatitis Therapeutics Market Size by Country (2017-2022) 9.4.2 Latin America Hepatitis Therapeutics Market Size by Country (2023-2028) 9.4.3 Mexico 9.4.4 Brazil 10 Middle East & Africa 10.1 Middle East & Africa Hepatitis Therapeutics Market Size (2017-2028) 10.2 Middle East & Africa Hepatitis Therapeutics Market Size by Type 10.2.1 Middle East & Africa Hepatitis Therapeutics Market Size by Type (2017-2022) 10.2.2 Middle East & Africa Hepatitis Therapeutics Market Size by Type (2023-2028) 10.2.3 Middle East & Africa Hepatitis Therapeutics Market Share by Type (2017-2028) 10.3 Middle East & Africa Hepatitis Therapeutics Market Size by Application 10.3.1 Middle East & Africa Hepatitis Therapeutics Market Size by Application (2017-2022) 10.3.2 Middle East & Africa Hepatitis Therapeutics Market Size by Application (2023-2028) 10.3.3 Middle East & Africa Hepatitis Therapeutics Market Share by Application (2017-2028) 10.4 Middle East & Africa Hepatitis Therapeutics Market Size by Country 10.4.1 Middle East & Africa Hepatitis Therapeutics Market Size by Country (2017-2022) 10.4.2 Middle East & Africa Hepatitis Therapeutics Market Size by Country (2023-2028) 10.4.3 Turkey 10.4.4 Saudi Arabia 10.4.5 UAE 11 Key Players Profiles 11.1 Gilead 11.1.1 Gilead Company Details 11.1.2 Gilead Business Overview 11.1.3 Gilead Hepatitis Therapeutics Introduction 11.1.4 Gilead Revenue in Hepatitis Therapeutics Business (2017-2022) 11.1.5 Gilead Recent Developments 11.2 Johnson & Johnson 11.2.1 Johnson & Johnson Company Details 11.2.2 Johnson & Johnson Business Overview 11.2.3 Johnson & Johnson Hepatitis Therapeutics Introduction 11.2.4 Johnson & Johnson Revenue in Hepatitis Therapeutics Business (2017-2022) 11.2.5 Johnson & Johnson Recent Developments 11.3 Bristol-Myers Squibb Company 11.3.1 Bristol-Myers Squibb Company Company Details 11.3.2 Bristol-Myers Squibb Company Business Overview 11.3.3 Bristol-Myers Squibb Company Hepatitis Therapeutics Introduction 11.3.4 Bristol-Myers Squibb Company Revenue in Hepatitis Therapeutics Business (2017-2022) 11.3.5 Bristol-Myers Squibb Company Recent Developments 11.4 Merck & Co.Inc. 11.4.1 Merck & Co.Inc. Company Details 11.4.2 Merck & Co.Inc. Business Overview 11.4.3 Merck & Co.Inc. Hepatitis Therapeutics Introduction 11.4.4 Merck & Co.Inc. Revenue in Hepatitis Therapeutics Business (2017-2022) 11.4.5 Merck & Co.Inc. Recent Developments 11.5 AbbVie Inc. 11.5.1 AbbVie Inc. Company Details 11.5.2 AbbVie Inc. Business Overview 11.5.3 AbbVie Inc. Hepatitis Therapeutics Introduction 11.5.4 AbbVie Inc. Revenue in Hepatitis Therapeutics Business (2017-2022) 11.5.5 AbbVie Inc. Recent Developments 12 Analyst's Viewpoints/Conclusions 13 Appendix 13.1 Research Methodology 13.1.1 Methodology/Research Approach 13.1.2 Data Source 13.2 Author Details 13.3 Disclaimer

List of Tables Table 1. Global Hepatitis Therapeutics Market Size Growth Rate by Type (US$ Million), 2017 VS 2021 VS 2028 Table 2. Key Players of Hepatitis Vaccine Table 3. Key Players of Anti-Viral Drugs Table 4. Global Hepatitis Therapeutics Market Size Growth Rate by Application (US$ Million), 2017 VS 2021 VS 2028 Table 5. Global Hepatitis Therapeutics Market Size by Region (US$ Million): 2017 VS 2021 VS 2028 Table 6. Global Hepatitis Therapeutics Market Size by Region (2017-2022) & (US$ Million) Table 7. Global Hepatitis Therapeutics Market Share by Region (2017-2022) Table 8. Global Hepatitis Therapeutics Forecasted Market Size by Region (2023-2028) & (US$ Million) Table 9. Global Hepatitis Therapeutics Market Share by Region (2023-2028) Table 10. Hepatitis Therapeutics Market Trends Table 11. Hepatitis Therapeutics Market Drivers Table 12. Hepatitis Therapeutics Market Challenges Table 13. Hepatitis Therapeutics Market Restraints Table 14. Global Hepatitis Therapeutics Revenue by Players (2017-2022) & (US$ Million) Table 15. Global Hepatitis Therapeutics Revenue Share by Players (2017-2022) Table 16. Global Top Hepatitis Therapeutics by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Hepatitis Therapeutics as of 2021) Table 17. Ranking of Global Top Hepatitis Therapeutics Companies by Revenue (US$ Million) in 2021 Table 18. Global 5 Largest Players Market Share by Hepatitis Therapeutics Revenue (CR5 and HHI) & (2017-2022) Table 19. Key Players Headquarters and Area Served Table 20. Key Players Hepatitis Therapeutics Product Solution and Service Table 21. Date of Enter into Hepatitis Therapeutics Market Table 22. Mergers & Acquisitions, Expansion Plans Table 23. Global Hepatitis Therapeutics Market Size by Type (2017-2022) & (US$ Million) Table 24. Global Hepatitis Therapeutics Revenue Market Share by Type (2017-2022) Table 25. Global Hepatitis Therapeutics Forecasted Market Size by Type (2023-2028) & (US$ Million) Table 26. Global Hepatitis Therapeutics Revenue Market Share by Type (2023-2028) Table 27. Global Hepatitis Therapeutics Market Size by Application (2017-2022) & (US$ Million) Table 28. Global Hepatitis Therapeutics Revenue Share by Application (2017-2022) Table 29. Global Hepatitis Therapeutics Forecasted Market Size by Application (2023-2028) & (US$ Million) Table 30. Global Hepatitis Therapeutics Revenue Share by Application (2023-2028) Table 31. North America Hepatitis Therapeutics Market Size by Type (2017-2022) & (US$ Million) Table 32. North America Hepatitis Therapeutics Market Size by Type (2023-2028) & (US$ Million) Table 33. North America Hepatitis Therapeutics Market Size by Application (2017-2022) & (US$ Million) Table 34. North America Hepatitis Therapeutics Market Size by Application (2023-2028) & (US$ Million) Table 35. North America Hepatitis Therapeutics Market Size by Country (2017-2022) & (US$ Million) Table 36. North America Hepatitis Therapeutics Market Size by Country (2023-2028) & (US$ Million) Table 37. Europe Hepatitis Therapeutics Market Size by Type (2017-2022) & (US$ Million) Table 38. Europe Hepatitis Therapeutics Market Size by Type (2023-2028) & (US$ Million) Table 39. Europe Hepatitis Therapeutics Market Size by Application (2017-2022) & (US$ Million) Table 40. Europe Hepatitis Therapeutics Market Size by Application (2023-2028) & (US$ Million) Table 41. Europe Hepatitis Therapeutics Market Size by Country (2017-2022) & (US$ Million) Table 42. Europe Hepatitis Therapeutics Market Size by Country (2023-2028) & (US$ Million) Table 43. Asia Pacific Hepatitis Therapeutics Market Size by Type (2017-2022) & (US$ Million) Table 44. Asia Pacific Hepatitis Therapeutics Market Size by Type (2023-2028) & (US$ Million) Table 45. Asia Pacific Hepatitis Therapeutics Market Size by Application (2017-2022) & (US$ Million) Table 46. Asia Pacific Hepatitis Therapeutics Market Size by Application (2023-2028) & (US$ Million) Table 47. Asia Pacific Hepatitis Therapeutics Market Size by Region (2017-2022) & (US$ Million) Table 48. Asia Pacific Hepatitis Therapeutics Market Size by Region (2023-2028) & (US$ Million) Table 49. Latin America Hepatitis Therapeutics Market Size by Type (2017-2022) & (US$ Million) Table 50. Latin America Hepatitis Therapeutics Market Size by Type (2023-2028) & (US$ Million) Table 51. Latin America Hepatitis Therapeutics Market Size by Application (2017-2022) & (US$ Million) Table 52. Latin America Hepatitis Therapeutics Market Size by Application (2023-2028) & (US$ Million) Table 53. Latin America Hepatitis Therapeutics Market Size by Country (2017-2022) & (US$ Million) Table 54. Latin America Hepatitis Therapeutics Market Size by Country (2023-2028) & (US$ Million) Table 55. Middle East and Africa Hepatitis Therapeutics Market Size by Type (2017-2022) & (US$ Million) Table 56. Middle East and Africa Hepatitis Therapeutics Market Size by Type (2023-2028) & (US$ Million) Table 57. Middle East and Africa Hepatitis Therapeutics Market Size by Application (2017-2022) & (US$ Million) Table 58. Middle East and Africa Hepatitis Therapeutics Market Size by Application (2023-2028) & (US$ Million) Table 59. Middle East and Africa Hepatitis Therapeutics Market Size by Country (2017-2022) & (US$ Million) Table 60. Middle East and Africa Hepatitis Therapeutics Market Size by Country (2023-2028) & (US$ Million) Table 61. Gilead Company Details Table 62. Gilead Business Overview Table 63. Gilead Hepatitis Therapeutics Product Table 64. Gilead Revenue in Hepatitis Therapeutics Business (2017-2022) & (US$ Million) Table 65. Gilead Recent Developments Table 66. Johnson & Johnson Company Details Table 67. Johnson & Johnson Business Overview Table 68. Johnson & Johnson Hepatitis Therapeutics Product Table 69. Johnson & Johnson Revenue in Hepatitis Therapeutics Business (2017-2022) & (US$ Million) Table 70. Johnson & Johnson Recent Developments Table 71. Bristol-Myers Squibb Company Company Details Table 72. Bristol-Myers Squibb Company Business Overview Table 73. Bristol-Myers Squibb Company Hepatitis Therapeutics Product Table 74. Bristol-Myers Squibb Company Revenue in Hepatitis Therapeutics Business (2017-2022) & (US$ Million) Table 75. Bristol-Myers Squibb Company Recent Developments Table 76. Merck & Co.Inc. Company Details Table 77. Merck & Co.Inc. Business Overview Table 78. Merck & Co.Inc. Hepatitis Therapeutics Product Table 79. Merck & Co.Inc. Revenue in Hepatitis Therapeutics Business (2017-2022) & (US$ Million) Table 80. Merck & Co.Inc. Recent Developments Table 81. AbbVie Inc. Company Details Table 82. AbbVie Inc. Business Overview Table 83. AbbVie Inc. Hepatitis Therapeutics Product Table 84. AbbVie Inc. Revenue in Hepatitis Therapeutics Business (2017-2022) & (US$ Million) Table 85. AbbVie Inc. Recent Developments Table 86. Research Programs/Design for This Report Table 87. Key Data Information from Secondary Sources Table 88. Key Data Information from Primary Sources List of Figures Figure 1. Global Hepatitis Therapeutics Market Share by Type: 2021 VS 2028 Figure 2. Hepatitis Vaccine Features Figure 3. Anti-Viral Drugs Features Figure 4. Global Hepatitis Therapeutics Market Share by Application: 2021 VS 2028 Figure 5. Hepatitis A Case Studies Figure 6. Hepatitis B Case Studies Figure 7. Hepatitis C Case Studies Figure 8. Alcoholic Hepatitis Case Studies Figure 9. Others Case Studies Figure 10. Hepatitis Therapeutics Report Years Considered Figure 11. Global Hepatitis Therapeutics Market Size (US$ Million), Year-over-Year: 2017-2028 Figure 12. Global Hepatitis Therapeutics Market Size, (US$ Million), 2017 VS 2021 VS 2028 Figure 13. Global Hepatitis Therapeutics Market Share by Region: 2021 VS 2028 Figure 14. Global Hepatitis Therapeutics Market Share by Players in 2021 Figure 15. Global Top Hepatitis Therapeutics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Hepatitis Therapeutics as of 2021) Figure 16. The Top 10 and 5 Players Market Share by Hepatitis Therapeutics Revenue in 2021 Figure 17. North America Hepatitis Therapeutics Market Size YoY (2017-2028) & (US$ Million) Figure 18. North America Hepatitis Therapeutics Market Size Market Share by Type (2017-2028) Figure 19. North America Hepatitis Therapeutics Market Size Market Share by Application (2017-2028) Figure 20. North America Hepatitis Therapeutics Market Size Share by Country (2017-2028) Figure 21. United States Hepatitis Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million) Figure 22. Canada Hepatitis Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million) Figure 23. Europe Hepatitis Therapeutics Market Size YoY (2017-2028) & (US$ Million) Figure 24. Europe Hepatitis Therapeutics Market Size Market Share by Type (2017-2028) Figure 25. Europe Hepatitis Therapeutics Market Size Market Share by Application (2017-2028) Figure 26. Europe Hepatitis Therapeutics Market Size Share by Country (2017-2028) Figure 27. Germany Hepatitis Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million) Figure 28. France Hepatitis Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million) Figure 29. U.K. Hepatitis Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million) Figure 30. Italy Hepatitis Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million) Figure 31. Russia Hepatitis Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million) Figure 32. Nordic Countries Hepatitis Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million) Figure 33. Asia-Pacific Hepatitis Therapeutics Market Size YoY (2017-2028) & (US$ Million) Figure 34. Asia Pacific Hepatitis Therapeutics Market Size Market Share by Type (2017-2028) Figure 35. Asia Pacific Hepatitis Therapeutics Market Size Market Share by Application (2017-2028) Figure 36. Asia Pacific Hepatitis Therapeutics Market Size Share by Region (2017-2028) Figure 37. China Hepatitis Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million) Figure 38. Japan Hepatitis Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million) Figure 39. South Korea Hepatitis Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million) Figure 40. Southeast Asia Hepatitis Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million) Figure 41. India Hepatitis Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million) Figure 42. Australia Hepatitis Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million) List of Figures Figure 43. Latin America Hepatitis Therapeutics Market Size YoY (2017-2028) & (US$ Million) Figure 44. Latin America Hepatitis Therapeutics Market Size Market Share by Type (2017-2028) Figure 45. Latin America Hepatitis Therapeutics Market Size Market Share by Application (2017-2028) Figure 46. Latin America Hepatitis Therapeutics Market Size Share by Country (2017-2028) Figure 47. Mexico Hepatitis Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million) Figure 48. Brazil Hepatitis Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million) Figure 49. Middle East & Africa Hepatitis Therapeutics Market Size YoY (2017-2028) & (US$ Million) Figure 50. Middle East and Africa Hepatitis Therapeutics Market Size Market Share by Type (2017-2028) Figure 51. Middle East and Africa Hepatitis Therapeutics Market Size Market Share by Application (2017-2028) Figure 52. Middle East and Africa Hepatitis Therapeutics Market Size Share by Country (2017-2028) Figure 53. Turkey Hepatitis Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million) Figure 54. Saudi Arabia Hepatitis Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million) Figure 55. UAE Hepatitis Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million) Figure 56. Gilead Revenue Growth Rate in Hepatitis Therapeutics Business (2017-2022) Figure 57. Johnson & Johnson Revenue Growth Rate in Hepatitis Therapeutics Business (2017-2022) Figure 58. Bristol-Myers Squibb Company Revenue Growth Rate in Hepatitis Therapeutics Business (2017-2022) Figure 59. Merck & Co.Inc. Revenue Growth Rate in Hepatitis Therapeutics Business (2017-2022) Figure 60. AbbVie Inc. Revenue Growth Rate in Hepatitis Therapeutics Business (2017-2022) Figure 61. Bottom-up and Top-down Approaches for This Report Figure 62. Data Triangulation Figure 63. Key Executives Interviewed

Gilead Johnson & Johnson Bristol-Myers Squibb Company Merck & Co.Inc. AbbVie Inc.